Altria CEO Sal Mancuso stated that the company's focus on responsibility is crucial for its FDA-regulated nicotine business, particularly for its "On!" nicotine pouch brand. He highlighted that regulatory hurdles, including lengthy review processes for Premarket Tobacco Product Applications (PMTA), are hindering growth and allowing illicit foreign products to gain market share. Altria has sued the FDA, seeking to streamline the authorization process for newer nicotine products and ensure a more equitable competitive landscape. AI
RANK_REASON Company sues regulatory body over product approval processes.
- Altria
- Black & Mild
- Helix Innovations
- James Wesley Hendrix
- Premarket Tobacco Product Application
- Sal Mancuso
- United States Food and Drug Administration
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →